StockData
Design Therapeutics, Inc. logo

Design Therapeutics, Inc. (DSGN) stock

DSGNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$9.32−0.15 (-1.58%)

Close on Nov 19, 2026Market cap $583.26MP/E –Yield –

Design Therapeutics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Design Therapeutics's revenue for the twelve months ending Jun 30, 2026 was $0. For fiscal 2025 it was $0.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$0–
FY2024Dec 31, 2024$0-100.0%
FY2020Dec 31, 2020$226.00K–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$0–
Q4 FY2025Dec 31, 2025$0-100.0%
Q3 FY2025Sep 30, 2025$0-100.0%
Q2 FY2025Jun 30, 2025$0-100.0%
Q1 FY2025Mar 31, 2025$0-100.0%
Q4 FY2020Dec 31, 2020$33.00K–
Q3 FY2020Sep 30, 2020$20.00K–
Q2 FY2020Jun 30, 2020$31.00K–
Q1 FY2020Mar 31, 2020$142.00K–

More Design Therapeutics figures

See a number that looks wrong?